Predictors of survival in glioblastoma patients treated with fotemustine at first relapse after Stupp regimen: Analysis of GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)

被引：0

作者：

Lombardi, G. ^{[1
]}

Scoccianti, S. ^{[2
]}

Fabrini, M. G. ^{[3
]}

Santoni, M. ^{[4
]}

Villani, V. ^{[5
]}

Silvani, A. ^{[6
]}

Marinelli, A. ^{[7
]}

Lolli, I. ^{[8
]}

Balducci, M. ^{[9
]}

Arcicasa, M. ^{[10
]}

Salvati, M. ^{[11
]}

Sponghini, A. ^{[12
]}

Vallarelli, S. ^{[13
]}

Caroli, M. ^{[14
]}

Imbesi, F. ^{[15
]}

Bilancia, D. ^{[16
]}

Faedi, M. ^{[17
]}

Zagonel, V. ^{[1
]}

Soffietti, R. ^{[18
,19
]}

Ruda, R. ^{[18
,19
]}

机构：

[1] Veneto Inst Oncol IRCCS, Dept Expt & Clin Oncol, Med Oncol 1, Padua, Italy

[2] AOU Careggi, Radiotherapy, Florence, Italy

[3] Azienda Osped Univ Pisana, Radiotherapy, Pisa, Italy

[4] Polytechinc Univ Marche Reg, Azienda Osped Univ, Med Oncol, Ancona, Italy

[5] Regina Elena Inst Canc Res, Neurooncol Unit, Rome, Italy

[6] Carlo Besta, Neurol, Milan, Italy

[7] Policlin Univ, Naples, Italy

[8] Saverio Bellis, Med Oncol, Castellana Grotte, Italy

[9] Catholic Univ Sacred Hearth, Radiat Oncol, Rome, Italy

[10] CRO Hosp, Radiotherapy, Aviano, Italy

[11] Hosp Rome, Umberto 1, Rome, Italy

[12] AOU Maggiore Carita, Dipartimento Oncol, Novara, Italy

[13] Azienda Osped, Policlin Bari, Bari, Italy

[14] Univ Milan, Neurosurg, Milan, Italy

[15] Osped Niguarda Ca Granda, Milan, Italy

[16] Azienda Osped, Reg San Carlo, Potenza, Italy

[17] Ist Sci Romagnolo Studio Cura Tumori IRST, Meldola, Italy

[18] Univ Turin, Turin, Italy

[19] City Hlth & Sci, Dept Neurooncol, Turin, Italy

来源：

EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷

关键词：

D O I：

10.1016/S0959-8049(15)30054-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2900

引用

页码：S584 / S584

页数：1

共 29 条

[1] Prognostic factors in glioblastoma patients treated with the nitrosourea fotemustine at first relapse after the Stupp regimen: results from the GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)
Santoni, M.
Lombardi, G.
Scoccianti, S.
Fabrini, M. G.
Silvani, A.
Villani, V.
Marinelli, A.
Lolli, I.
Balducci, M.
Arcicasa, M.
Salvati, M.
Sponghini, A. P.
Vallarelli, S.
Caroli, M.
Imbesi, F.
Bilancia, D.
Faedi, M.
Cascinu, S.
Soffietti, R.
Ruda, R.
ANNALS OF ONCOLOGY, 2015, 26 : 133 - 133
[2] GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology): Analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first relapse following Stupp regimen.
Ruda, Roberta
Lombardi, Giuseppe
Scoccianti, Silvia
Fabrini, Maria Grazia
Santoni, Matteo
Pace, Andrea
Silvani, Antonio
Marinelli, Alfredo
Lolli, Ivan
Balducci, Mario
Arcicasa, Mauro
Salvati, Maurizio
Sponghini, Andrea
Vallarelli, Simona
Caroli, Manuela
Imbesi, Francesca
Bilancia, Domenico
Faedi, Marina
Cascinu, Stefano
Soffietti, Riccardo
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[3] GLIOSTRY (GLIOBLASTOMA REGISTRY) OF THE AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY): FINAL ANALYSIS OF FACTORS INFLUENCING SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING THE NITROSOUREA FOTEMUSTINE AT FIRST PROGRESSION FOLLOWING CHEMORADIATION.
Ruda, R.
Lombardi, G.
Scoccianti, S.
Pasqualetti, F.
Silvani, A.
Pace, A.
Arcicasa, M.
Salvati, M.
Caroli, M.
Soffietti, R.
NEURO-ONCOLOGY, 2016, 18 : 48 - 48
[4] Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
Riccardo Soffietti
Elisa Trevisan
Luca Bertero
Paola Cassoni
Isabella Morra
Maria Grazia Fabrini
Francesco Pasqualetti
Ivan Lolli
Anna Castiglione
Giovannino Ciccone
Roberta Rudà
Journal of Neuro-Oncology, 2014, 116 : 533 - 541
[5] Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
Soffietti, Riccardo
Trevisan, Elisa
Bertero, Luca
Cassoni, Paola
Morra, Isabella
Fabrini, Maria Grazia
Pasqualetti, Francesco
Lolli, Ivan
Castiglione, Anna
Ciccone, Giovannino
Ruda, Roberta
JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (03) : 533 - 541
[6] Clinical and molecular predictors of survival in elderly glioblastoma patients treated with radiotherapy and concomitant temozolomide: a multicenter study of aino (Italian Association of Neuro-Oncology)
Lombardi, G.
Pace, A.
Pasqualetti, F.
Rizzato, S.
Faedi, M.
Anghileri, E.
Nicolotto, E.
Bazzoli, E.
Bellu, L.
Villani, V.
Fabi, A.
Ferrazza, P.
Gurrieri, L.
Dall'Agata, M.
Eoli, M.
Della Puppa, A.
Pambuku, A.
Berti, F.
Ruda, R.
Zagonel, V.
ANNALS OF ONCOLOGY, 2015, 26 : 136 - 136
[7] Bevacizumab and Fotemustine for Recurrent Glioblastoma - Final Results of a Multicenter Phase II Study of AINO (Italian Association of Neuro-Oncology)
Trevisan, E.
Ruda, R.
Bertero, L.
Bosa, C.
Ciccone, G.
Morra, I.
Fabrini, M. G.
Lolli, I.
Soffietti, R.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S576 - S576
[8] A PHASE II STUDY OF AINO (ITALIAN ASSOCIATIONOF NEURO-ONCOLOGY) ON BEVACIZUMAB AND FOTEMUSTINE FOR RECURRENT GLIOBLASTOMA: OUTCOME, PATTERNS OF RELAPSE AND SALVAGE TREATMENTS
Trevisan, E.
Bertero, L.
Cassoni, P.
Morra, I.
Pasqualetti, F.
Lolli, I.
Castiglione, A.
Ciccone, G.
Ruda, R.
Soffietti, R.
NEURO-ONCOLOGY, 2014, 16
[9] PHASE II TRIAL OF BEVACIZUMAB WITH FOTEMUSTINE IN RECURRENT GLIOBLASTOMA: FINAL RESULTS OF A MULTICENTER STUDY OF AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY)
Soffietti, Riccardo
Trevisan, Elisa
Ruda, Roberta
Bertero, Luca
Bosa, Chiara
Fabrini, Maria Grazia
Lolli, Ivan
NEURO-ONCOLOGY, 2011, 13 : 56 - 57
[10] Phase II trial of bevacizumab with fotemustine in recurrent glioblastoma: Final results of a multicenter study of AINO (Italian Association of Neuro-oncology).
Soffietti, R.
Trevisan, E.
Ruda, R.
Bertero, L.
Bosa, C.
Fabrini, M. G.
Lolli, I.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

← 1 2 3 →